Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
US8481070B2 · kind B2 · utility
0Cited by
6References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2009 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Jul 12, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.